Lista de obras - Patricia Njuguna - Dominio Público Uruguay

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

artículo científico publicado en 2012

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 E on blood stage immunity in young Kenyan children.

artículo científico publicado en 2019

Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study

artículo científico publicado en 2016

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care

artículo científico publicado en 2011

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children

artículo científico publicado en 2014

Clinical indicators of bacterial meningitis among neonates and young infants in rural Kenya

artículo científico publicado en 2011

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

article by Angela Huttner et al published July 2018 in Lancet Infectious Diseases

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children ⬇️

artículo científico publicado en 2011

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial

artículo científico publicado en 2011

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

artículo científico publicado en 2008

Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection

artículo científico publicado en 2014

Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis

artículo científico publicado en 2011

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

artículo científico publicado en 2011

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure

artículo científico publicado en 2013

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

artículo científico publicado en 2015

International health research monitoring: exploring a scientific and a cooperative approach using participatory action research

artículo científico publicado en 2014

Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial

artículo científico publicado en 2016

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

artículo científico publicado en 2019

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children

artículo científico publicado en 2010

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

artículo científico publicado en 2019

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

artículo científico publicado en 2016

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

artículo científico publicado en 2022

Lista de obras de Patricia Njuguna

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 E on blood stage immunity in young Kenyan children.

Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children

Clinical indicators of bacterial meningitis among neonates and young infants in rural Kenya

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children ⬇️

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection

Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

International health research monitoring: exploring a scientific and a cooperative approach using participatory action research

Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study